Elisa Uliassi

Pharmacy and Biotechnology University of Bologna 
"Elisa Uliassi"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Exertier C, Salerno A, Antonelli L, et al. (2024) Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis. Journal of Medicinal Chemistry. 67: 402-419
Albertini C, Salerno A, Atzeni S, et al. (2022) Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis. Acs Chemical Neuroscience
Gorecki L, Uliassi E, Bartolini M, et al. (2021) Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease. Acs Chemical Neuroscience. 12: 1698-1715
Perone R, Albertini C, Uliassi E, et al. (2021) Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy. Chemmedchem. 16: 187-198
Bruno S, Uliassi E, Zaffagnini M, et al. (2017) Molecular basis for covalent inhibition of glyceraldehyde-3-phosphate dehydrogenase by a 2-phenoxy-1,4-naphthoquinone small molecule. Chemical Biology & Drug Design
Junker A, Balasubramanian R, Ciancetta A, et al. (2016) Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists. Journal of Medicinal Chemistry
Kiselev E, Balasubramanian R, Uliassi E, et al. (2015) Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y14 receptor. Bioorganic & Medicinal Chemistry Letters. 25: 4733-9
See more...